BT8009-100: Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies
-
Enrollment
This study is currently enrolling. -
Research Area
Cancer Research -
Location
-
Principal Investigator
-
Sponsor
BicycleTx Ltd
Enrollment Form
This study is currently enrolling.